Soligenix Inc. (NASDAQ:SNGX) shares surged on Thursday as the company announced positive results from its Phase 2a ...

Behçet's disease is a complex, multisystem inflammatory disorder characterised by recurrent mucocutaneous lesions, ocular involvement, and vascular, neurological, and gastrointestinal manifestations.

SNGX READ THE FULL SNGX RESEARCH REPORT Business Update Encouraging Results from Phase2a Trial of SGX945 in Behcet’s Disease ...

Biomarkers in the Evaluation of Disease Activity in Behçet's Disease Patients Commenting is limited to medical professionals. To comment please Log-in.

There are approximately 18,000 known cases of Behçet's Disease in the U.S. and 80,000 in Europe. There are as many as 1,000,000 people worldwide living with Behçet's Disease.

Wenjie Zheng, Xiaoman Wang, Jinjing Liu, Xin Yu, Lu Li, Heping Wang, Jijun Yu, Xiaoya Pei, Chaoran Li, Zhimian Wang, Menghao Zhang, Xiaofeng Zeng, Fengchun Zhang, Chenfei Wang, Hua Chen, Hou-Zao Chen, ...

The FDA has approved Gamifant as the first-ever treatment for macrophage activation syndrome in Still’s disease for adults and children who have an inadequate response or intolerance to ...

Behçet's disease (BD) is a multisystem inflammatory disorder currently classified as a vasculitis. Its etiopathogenesis is unclear, but environmental, genetic and autoimmune factors have been ...